MA S 895
in committeeAn Act to promote transparency and prevent price gouging of pharmaceutical drug prices
Massachusetts · 2025-2026 Regular Session (194th General Court) · upper
Quick answers
Did MA S 895 pass?
Not yet. MA S 895 is in committee as of 2025-06-16 and has not come to a final vote. Latest recorded action (2025-06-16): Accompanied S868
What is MA S 895 about?
By Mr. Montigny, a petition (accompanied by bill, Senate, No. 895) of Mark C. Montigny for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices. Health Care Financing.
Who sponsors MA S 895?
Mark C. Montigny is the primary sponsor of MA S 895.
Description
By Mr. Montigny, a petition (accompanied by bill, Senate, No. 895) of Mark C. Montigny for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices. Health Care Financing.
- Introduced
- —
- Latest action
- 2025-06-16 — Accompanied S868
- Bill type
- bill
- Last updated
- —
Sponsors
- Mark C. Montignyprimary
Committees
Not provided by source.
Action timeline
2025-02-27
Referred to the committee on Health Care Financing
referral-committee
2025-02-27
House concurred
2025-05-22
Hearing scheduled for 06/02/2025 from 11:00 AM-03:00 PM in Gardner Auditorium
2025-06-16
Accompanied S868
Versions
- Bill TextCompare
Documents
Votes
Not provided by source.
Related bills
- Replaces: SD 2517
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:56.590024Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MA&identifier=S 895. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.